Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teladoc HealthSTU:4LL +2.22%51 Debt-to-EBITDA is 4.35 as of Jun. 2026. GuruFocus rates STU:4LL with a GF Score™ of 51/100 and a GF Value™ of €47.55 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Teladoc Health ranks worse than 73.58% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Teladoc Health's Debt-to-EBITDA or its related term are showing as below:
STU:4LL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -15.26 Med: -2.82 Max: 10.52
Current: 4.81
During the past 13 years, the highest Debt-to-EBITDA Ratio of Teladoc Health was 10.52. The lowest was -15.26. And the median was -2.82.
STU:4LL's Debt-to-EBITDA is ranked worse than 73.58% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.21
vs STU:4LL: 4.81
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Teladoc Health Debt-to-EBITDA Related Terms
Teladoc Health Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Teladoc Health's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:4LL vs OMCL, OMDA, CERT: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Teladoc Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teladoc Health Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Teladoc Health's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Teladoc Health (STU:4LL) has a Debt-to-EBITDA of 4.35 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Teladoc Health. According to the industry distribution chart, Teladoc Health ranks #351 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 73.6%.
Is Teladoc Health's Debt-to-EBITDA too high?
Teladoc Health's current Debt-to-EBITDA is 4.35. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.21. Teladoc Health's value of 4.35 is 96.8% above this industry median. Based on the distribution chart, Teladoc Health ranks #351 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Teladoc Health has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's Debt-to-EBITDA compare to OMCL and OMDA?
According to the Healthcare Providers & Services industry distribution chart, Teladoc Health ranks #351 out of 477 companies for Debt-to-EBITDA. This places Teladoc Health in the lower half of its industry. The industry median Debt-to-EBITDA is 2.21. Teladoc Health's value of 4.35 is 96.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teladoc Health's current Debt-to-EBITDA of 4.35 is 96.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Teladoc Health. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teladoc Health's current Debt-to-EBITDA is 4.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Possible Value Trap. The stock's GF Value™ is €47.55, compared to a current price of €5.81 — trading 87.8% below its estimated fair value. The current Debt-to-EBITDA is 4.35 and 96.8% above the Healthcare Providers & Services industry median of 2.21. Teladoc Health's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current Debt-to-EBITDA is 4.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teladoc Health (STU:4LL) Overvalued in 2026?
Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued.
The current stock price of €5.81 is trading 87.8% below its estimated GF Value™ of €47.55.
GuruFocus considers Teladoc Health to be Possible Value Trap.
Key valuation signals for STU:4LL:
Debt-to-EBITDA: 4.35
GF Value™: €47.55 vs. price of €5.81 (87.8% below fair value)
Industry Position: 96.8% above the Healthcare Providers & Services median (#351 of 477)
No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
51GF Score
Get the complete analysis for STU:4LL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:4LL has been successfully added to your 
